Algorae Pharmaceuticals Limited

Algorae Pharmaceuticals Limitedverified

LVCLF

Price:

$0.0049

Market Cap:

$24.53M

Algorae Pharmaceuticals Limited, a pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand. The company's product pipeline includes AI-116, a novel combination drug candidate, which includes cannabidiol and an off-patent pharmaceutical ingredient for the of treatment for dementia, including Alzheimer's disease; NTCELL, an alginate coated capsule to target the treatment of Parkinson's disease; and AI-168, a novel combination drug candidate made up of a cannabinoid and an off-patent pharmaceutical ingredient to treat cardiovascular disease, including hypertension. It is also developing AlgaraeOS in partnership with the U...[Read more]

Industry

Biotechnology

IPO Date

2010-06-01

Stock Exchange

OTC

Ticker

LVCLF

The ROE as of December 2025 (TTM) for Algorae Pharmaceuticals Limited (LVCLF) is -61.85%

According to Algorae Pharmaceuticals Limited’s latest financial reports and current stock price. The company's current ROE is -61.85%. This represents a change of 91.59% compared to the average of -32.28% of the last 4 quarters.

Algorae Pharmaceuticals Limited (LVCLF) Historical ROE (quarterly & annually)

How has LVCLF ROE performed in the past?

The mean historical ROE of Algorae Pharmaceuticals Limited over the last ten years is -64.22%. The current -61.85% ROE has changed -3.69% with respect to the historical average. Over the past ten years (40 quarters), LVCLF's ROE was at its highest in in the June 2018 quarter at 20.09%. The ROE was at its lowest in in the June 2007 quarter at -213.63%.

Quarterly (TTM)
Annual

Average

-64.22%

Median

-55.26%

Minimum

-137.38%

Maximum

-5.25%

Algorae Pharmaceuticals Limited (LVCLF) ROE by Quarter and Year

Discovering the peaks and valleys of Algorae Pharmaceuticals Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.36%

Maximum Annual ROE = -5.25%

Minimum Annual Increase = -90.35%

Minimum Annual ROE = -137.38%

Quarterly (TTM)
Annual
YearROEChange
2024-69.52%24.09%
2023-56.02%15.49%
2022-48.51%-54.26%
2021-106.06%215.22%
2020-33.65%-56.23%
2019-76.87%1.36%
2018-5.25%-90.35%
2017-54.40%-0.16%
2016-54.49%-60.34%
2015-137.38%70.88%

Algorae Pharmaceuticals Limited (LVCLF) Average ROE

How has LVCLF ROE performed in the past?

The current ROE of Algorae Pharmaceuticals Limited (LVCLF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-58.02%

5-year avg

-62.75%

10-year avg

-64.22%

Algorae Pharmaceuticals Limited (LVCLF) ROE vs. Peers

How is LVCLF’s ROE compared to its peers?

Algorae Pharmaceuticals Limited’s ROE is greater than HOOKIPA Pharma Inc. (-120.60%), greater than Oxford BioDynamics Plc (-244.86%), greater than Devonian Health Group Inc. (-33.54%), less than EOM Pharmaceuticals Holdings, Inc. (59.97%), less than Nymox Pharmaceutical Corporation (24.07%), less than Hemostemix Inc. (68.24%), less than Sirona Biochem Corp. (221.45%), less than LianBio (0.77%), less than Valeo Pharma Inc. (95.58%), greater than Propanc Biopharma, Inc. (-601.00%),

Build a custom stock screener for Algorae Pharmaceuticals Limited (LVCLF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Algorae Pharmaceuticals Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Algorae Pharmaceuticals Limited (LVCLF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Algorae Pharmaceuticals Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Algorae Pharmaceuticals Limited's ROE?

How is the ROE calculated for Algorae Pharmaceuticals Limited (LVCLF)?

What is the highest ROE for Algorae Pharmaceuticals Limited (LVCLF)?

What is the 3-year average ROE for Algorae Pharmaceuticals Limited (LVCLF)?

What is the 5-year average ROE for Algorae Pharmaceuticals Limited (LVCLF)?

How does the current ROE for Algorae Pharmaceuticals Limited (LVCLF) compare to its historical average?